HelenMaMD

PubMed

• Survival in Agent Orange exposed and unexposed Vietnam-era veterans who were diagnosed with lymphoid malignancies.
  Jia Y Wan, Victoria K Cortessis, Wendy Cozen, Helen Ma, Pankaj Gupta> ;Blood Advances. 2024 Feb 27
• A retrospective analysis of factors impacting survival in United States military veterans with multiple myeloma.
  Gupta, P., Mahmood, S., Ma, H.> ;Leukemia & Lymphoma. 2024 Apr 1
• Mature T-cell and NK-cell lymphoma involvement of the central nervous system: a single center experience.
  Helen Ma, Enrica Marchi, Owen A O'Connor, Jennifer K Lue> ;Leukemia & Lymphoma. 2023 Dec 1
• How we approach the perioperative management of patients with chronic lymphocytic leukaemia receiving continuous cancer-directed therapies.
  Helen Ma, Stephani Wang, Susan O'Brien, Morton Kern, Pankaj Gupta> ;British Journal of Haematology. 2023 Apr 1
• 3 citations
  Management of Angioimmunoblastic T-Cell Lymphoma (AITL) and other T Follicular Helper Cell lymphomas (TFH PTCL).
  Helen Ma, Owen A. O'Connor, Enrica Marchi> ;Seminars in Hematology. 2021 Mar 19
• 29 citations
  First-in-Class Selective HDAC6 Inhibitor (ACY-1215) Has a Highly Favorable Safety Profile in Patients with Relapsed and Refractory Lymphoma.
  Jennifer E Amengual, Jennifer K. Lue, Helen Ma, Renee Lichtenstein, Bijal D. Shah, Serge Cremers, Simon S. Jones, Ahmed Sawas> ;The Oncologist. 2021 Mar 1
• 77 citations
  Combined oral 5-azacytidine and romidepsin are highly effective in patients with PTCL: a multicenter phase 2 study.
  Lorenzo Falchi, Helen Ma, Sandra Klein, Jennifer K. Lue, Francesca Montanari, Enrica Marchi, Changchun Deng, Hye A. Kim, Aishling M. Rada, Alice T. Jacob, Cristina Kin...> ;Blood. 2020 Nov 10
• 14 citations
  The peripheral T-cell lymphomas: an unusual path to cure.
  Helen Ma, Enrica Marchi, Owen A. O'Connor> ;The Lancet. Haematology. 2020 Oct 1
• 2 citations
  Low dose continuous lenalidomide in heavily pretreated patients with relapsed or refractory classical Hodgkin lymphoma: a retrospective case series.
  Helen Ma, Bin Cheng, Francesca Montanari, Jennifer K. Lue, Changchun Deng, Enrica Marchi, Owen A O' Connor, Ahmed Sawas> ;Therapeutic Advances in Hematology. 2020 Sep 26
• Cancer testis antigen expression across T-cell lymphoma subtypes
  Helen Ma, Craig R. Soderquist, Enrica Marchi, Luigi Scotto, Govind Bhagat, Owen A. O'Connor> ;Hematological Oncology. 2020 Aug 14
• 1 citations
  Generation of pralatrexate resistant T-cell lymphoma lines reveals two patterns of acquired drug resistance that is overcome with epigenetic modifiers.
  Luigi Scotto, Cristina Kinahan, Beatrice Casadei, Michael Mangone, Eugene Douglass, Vundavalli V. Murty, Enrica Marchi, Helen Ma, Changchun George, Francesca Montanari...> ;Genes, Chromosomes & Cancer. 2020 Jul 30
• 1 citations
  Prolonged progression free survival in a subset of responders to the combination of brentuximab vedotin and bendamustine in heavily treated patients with relapsed or r...
  Ahmed Sawas, Helen Ma, John Kuruvilla, Jennifer K. Lue, Changchun Deng, Enrica Marchi, Francesca Montanari, Bin Cheng, Kerry J. Savage, Diego Villa, Michael Crump, Jos...> ;Leukemia & Lymphoma. 2020 Jul 28
• 4 citations
  Characterizing the belinostat response in patients with relapsed or refractory angioimmunoblastic T-cell lymphoma
  Ahmed Sawas, Helen Ma, Andrei R. Shustov, Pamela Hsu, Gajanan Bhat, Mark Acosta, Steven M. Horwitz, Owen A. O'Connor> ;Leukemia & Lymphoma. 2020 Apr 26
• 15 citations
  Survival benefit in patients with peripheral T-cell lymphomas after treatments with novel therapies and clinical trials.
  Helen Ma, Bin Cheng, Lorenzo Falchi, Enrica Marchi, Ahmed Sawas, Govind Bhagat, Owen A. O'Connor> ;Hematological Oncology. 2020 Feb 1
• 18 citations
  Outcomes in patients with aggressive B-cell non-Hodgkin lymphoma after intensive frontline treatment failure
  Emily C. Ayers, Shaoying Li, L. Jeffrey Medeiros, David A. Bond, Kami J. Maddocks, Pallawi Torka, Angel Mier Hicks, Madeira Curry, Nina D. Wagner-Johnston, Reem Karmal...> ;Cancer. 2020 Jan 15
• 1 citations
  A peripheral T-cell lymphoma (PTCL) arising as a post-transplant lymphoproliferative disorder: efficacy of pralatrexate in primary refractory disease and review of the...
  Helen Ma, Govind Bhagat, Owen A. O'Connor> ;Leukemia & Lymphoma. 2019 Jun 11
• 11 citations
  New directions in treating peripheral T-cell lymphomas (PTCL): leveraging epigenetic modifiers alone and in combination.
  Helen Ma, Owen A. O'Connor, Enrica Marchi> ;Expert Review of Hematology. 2019 Feb 27
• 7 citations
  Combining Biology and Chemistry for a New Take on Chemotherapy: Antibody-Drug Conjugates in Hematologic Malignancies.
  Helen Ma, Ahmed Sawas> ;Current Hematologic Malignancy Reports. 2018 Dec 1
• 18 citations
  The Future of Combination Therapies for Peripheral T Cell Lymphoma (PTCL).
  Helen Ma, Ardy Davarifar, Jennifer E Amengual> ;Current Hematologic Malignancy Reports. 2018 Feb 1
• 12 citations
  Potentially inappropriate medication use in elderly non-Hodgkin lymphoma patients is associated with reduced survival and increased toxicities.
  Richard J. Lin, Helen Ma, Robin Guo, Andrea B. Troxel, Catherine Diefenbach> ;British Journal of Haematology. 2018 Jan 1
• 12 citations
  A Web-based Multimedia Program Before Colonoscopy Increased Knowledge and Decreased Anxiety, Sedation Requirement, and Procedure Time.
  Siddhartha Parker, Jonathan S. Zipursky, Helen Ma, Geri Lynn Baumblatt, Corey A. Siegel> ;Journal of Clinical Gastroenterology. 2017 Oct 1
• 21 citations
  T-cell lymphomas, a challenging disease: types, treatments, and future
  Helen Ma, Maher Abdul-Hay> ;International Journal of Clinical Oncology. 2017 Feb 1
• Join now to see all

Abstracts/Posters

• Belinostat Induces High Overall Response Rate (ORR) in Patients with Relapsed or Refractory Angioimmunoblastic T-Cell Lymphoma (AITL)
  Helen Ma, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

• Novel Drugs and Clinical Trial-Based Treatments Prolong Survival of Peripheral T-Cell Lymphomas (PTCL) Patients: Single Institution Retrospective Analysis 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Survival outcomes of patients with peripheral T-cell lymphomas (PTCL) treated with chemotherapy and/or novel agents: The Columbia University experience. 
  2019 ASCO Annual Meeting - 6/1/2019